Literature DB >> 329743

Psychomotor skills during acute and two-week treatment with mianserin (ORG GB 94) and amitriptyline, and their combined effects with alcohol.

T Seppälä.   

Abstract

Twenty paid healthy volunteers took a placebo, 10 mg of mianserin and 25 mg of amitriptyline, t.i.d. for two weeks each, in a double-blind cross-over manner. There was one week's "wash-out" between the treatments. Several psychomotor tests were done on the first, 7th and 14th days of each period with either alcohol (0.5 g/kg) or a placebo drink. Co-ordinative and reactive skills and critical flicker frequency were affected by all the drug-drink combinations while attention was slightly impaired only after amitriptyline alone or mianserin together with alcohol. Drug actions and drug-alcohol interactions were most obvious on the first day but declined towards the end of the drug periods. After mianserin the skills were impaired on the first day only, but after amitriptyline up to the 7th day in most of the tests. Both drugs seemed to interact additively with alcohol. Impairment of flicker fusion by amitriptyline + alcohol remained constant over the whole 2-week period. Psychomotor effects of antidepressants have practical importance in the acute phase of treatment. Their concurrent use with alcohol must increase accident risk in traffic.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 329743

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN: 0003-4762


  18 in total

1.  Echocardiographic and psychometric effects of amitriptyline or imipramine plus alcohol.

Authors:  C Strömberg; A Suokas; T Seppälä; M Kupari
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo.

Authors:  J G Ramaekers; H F Swijgman; J F O'Hanlon
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Acute and subacute effects on psychomotor performance of femoxetine alone and with alcohol.

Authors:  C Strömberg; M J Mattila
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Mianserin: a decade of scientific development.

Authors:  M Peet; H Behagel
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

Review 5.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

6.  Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients.

Authors:  B Spring; A J Gelenberg; R Garvin; S Thompson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Effects of zimeldine, mianserin and amitriptyline on psychomotor skills and their interaction with ethanol a placebo controlled cross-over study.

Authors:  T Seppälä; C Strömberg; I Bergman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Effects of amitriptyline and mianserin on psychomotor skills and memory in man.

Authors:  M J Mattila; R Liljequist; T Seppälä
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

9.  Ethanol effects on brain concentrations of amitriptyline and the relationship to psychomotor function.

Authors:  S H Preskorn; C W Hughes
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Acute and subchronic effects of Org 2305 and diazepam on psychomotor performance in man.

Authors:  M J Mattila; J Koski; C Strömberg
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.